← Back to headlines
KOSDAQ-Listed Bio Firm Under Review for Unfaithful Disclosure
A bio firm listed on the KOSDAQ exchange is set to undergo a review due to unfaithful disclosure practices. This action highlights regulatory scrutiny over corporate transparency in South Korea's stock market.
16 Apr, 02:47 — 16 Apr, 02:47
Sources
Showing 1 of 1 sources
Related Stories
Markets Rally as Fed’s Waller Signals Potential September Rate Pause
2h ago
Netherlands Transfers Billions in Gold Reserves From U.S. to London
6h ago
Jet2 Upgrades to London Stock Exchange Main Market After Strong Summer
9h ago
Netherlands Relocates Gold Reserves to London Amid Geopolitical Tensions
12h ago